Sight Sciences, Inc. Share Price & Technical Analysis
SGHT · $4.86 (-3.38%)
Healthcare / Medical Devices
$4.86
-3.38%
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal vi…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
22% return in May, 12% avg return in past 3 year May month.
-33% return in 2026, 37% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -20% | -16% | -27% | 8% | 22% | – | – | – | – | – | – | – | -33% |
| 25 | -24% | 0% | -11% | 25% | 19% | 11% | -20% | 28% | -15% | 50% | 65% | -5% | 123% |
| 24 | -18% | -7% | 33% | 6% | 18% | 2% | 16% | -13% | -6% | -21% | -20% | -10% | -20% |
| 23 | -10% | -4% | -21% | 10% | -1% | -13% | 7% | -25% | -48% | -53% | 113% | 53% | 7% |
| 22 | -17% | 19% | -34% | -40% | 25% | 3% | 3% | -24% | -9% | 24% | 40% | 8% | -1% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$262.80M
P/E ratio
—
52W high
$9.24
52W low
$3.11
Volume
70,097
Beta
2.38
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Sight Sciences, Inc. share price today?
- Sight Sciences, Inc. (SGHT) last traded around $4.86 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SGHT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SGHT. Download the app for real-time alerts.
- How can I analyze Sight Sciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.